Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 意见
• 07/30/23
0
0
嵌入
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论